NIH supports investigator-initiated observational or biomarker validation studies requiring prospective collection or continued analysis of data or biospecimens; clinical trials are not allowed.
The National Cancer Institute funds cancer epidemiology cohort research on cancer causes and survivorship, including cohort upkeep, follow-up, and data and biospecimen sharing; clinical trials are not allowed.
Supports investigator-initiated, milestone-driven clinical trials requiring enhanced oversight for up to 7 years, with mechanistic studies as applicable and one trial per application.
NCI supports research on how biospecimen collection, processing, and storage affect biomarkers, aiming to standardize handling and improve clinical assay development; clinical trials are not allowed.
Renewal opportunity for ongoing NINDS-supported clinical trials needing more time and resources via U01 cooperative agreements.
Supports laboratory optimization and clinical validation of cancer biomarkers and assays using human samples to address defined clinical needs; clinical trials are not allowed.